Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale patents


Recent patent applications related to Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale. Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale is listed as an Agent/Assignee. Note: Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale may have other listings under different names/spellings. We're not affiliated with Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale-related inventors


Methods for predicting graft alterations

The invention relates to a method for predicting graft alterations in a transplanted patient, comprising a step of determining the expression levels of bactericidal/permeability-increasing protein (BPI), chemokine (C motif) ligand 1 (XCL1) and thioredoxin domain containing 3 (TXNDC3) genes in a biological sample obtained from said transplanted patient.... Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale

Use of low dose il-2 for treating autoimmune – related or inflammatory disorders

The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.... Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale

Dual targeting of tafi and pai-1

... Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale

Sulphate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine, preparation thereof and use of the same

The present invention relates to sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine and pharmaceutically acceptable solvates thereof, preparation thereof, pharmaceutical compositions containing them and use of the same in the treatment and/or prevention of neurodegenerative diseases.... Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale

Method for preparing porous scaffold for tissue engineering, cell culture and cell delivery

The present invention relates to a method for preparing a porous scaffold for tissue engineering. It is another object of the present invention to provide a porous scaffold obtainable by the method as above described, and its use for tissue engineering, cell culture and cell delivery. The method of the... Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale

Prenatal therapy to induce immune tolerance

Constructs and methods for inducing immune tolerance during gestation, e.g. in utero, are provided. The constructs comprise a moiety that targets and binds to the neonatal Fc receptor (FcRn) and a moiety comprising an antigen of interest for which immune tolerance is desired. Administration of the constructs to a fetus... Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale

Antibodies for the prevention or the treatment of bleeding episodes

The invention relates to an isolated monoclonal antibody that specifically binds to the D4 domain of VWF, competes for binding to VWF D4 domain with ADAMTS13 and partially inhibits ADAMTS 13 -mediated degradation of VWF. More particularly, the invention relates to an isolated monoclonal antibody comprising a heavy chain wherein... Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale

Novel immunoadjuvant flagellin-based compounds and use thereof

The present invention relates to novel peptide compounds derived from flagellin originating from Salmonelle enterica that exhibit an in vivo immune adjuvant activity.... Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Inserm institut National De La Sant xe9 Et De La Recherche M xe9 dicale with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###